JOHN W KOZARICH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN W KOZARICH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN W KOZARICH. JOHN W KOZARICH is a Director in LIGAND PHARMACEUTICALS INC ($LGND) and a Director in QLT INC/BC ($QLTI) and a Director in Retrophin, Inc. ($RTRX) and a Director in Intec Pharma Ltd. ($NTEC).
Address: 10275 SCIENCE CENTER DR SAN DIEGO 92121 CA
Companies in which JOHN W KOZARICH is an Insider
Intec Pharma Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN W KOZARICH: Director
Holdings: 151,761 shares
Latest Transaction: Jul 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LIGAND PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN W KOZARICH: Director
Holdings: 34,543 shares
Current Value: $3,725,117
Latest Transaction: May 13 2021
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVELION THERAPEUTICS INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN W KOZARICH: Director
Holdings: 57,000 shares
Latest Transaction: Jun 21 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN W KOZARICH: Director
Holdings: 29,000 shares
Current Value: $582,030
Latest Transaction: May 10 2019
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of JOHN W KOZARICH
Sentiment: All, NTEC, LGND, NVLN, RTRX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | M | 10.12 | 4,835 | 48,930 | 0 | |
| May 13 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Payment of Exercise | F | 128.56 | 391 | 50,267 | 34,152 | 34.5 K to 34.2 K (-1.13 %) |
| May 13 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | M | 10.12 | 4,835 | 48,930 | 34,543 | 29.7 K to 34.5 K (+16.28 %) |
| Feb 23 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | M | 10.12 | 2,500 | 25,300 | 4,835 | |
| Feb 23 2021 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | M | 10.12 | 2,500 | 25,300 | 29,708 | 27.2 K to 29.7 K (+9.19 %) |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | KOZARICH JOHN W | Director | Option Exercise | A | 0.31 | 40,000 | 12,300 | 40,000 | |
| Jun 12 2020 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 117.58 | 2,468 | 290,187 | 2,468 |